Methylprednisolone inhibits IFN-γ and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis

Journal of Neuroinflammation

Volumn 6, Issue , 2009, Pages

  Miljković, Željka ^a   Momčilović, Miljana ^a   Miljković, Djordje ^a   Mostarica Stojković, Marija ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; METHYLPREDNISOLONE; MIFEPRISTONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HORMONE ANTAGONIST; LEUKOCYTE ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOLOGY; RAT STRAIN;

ANIMALS; ANTIGENS, CD; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLUCOCORTICOIDS; HORMONE ANTAGONISTS; INTERFERON-GAMMA; INTERLEUKIN-17; METHYLPREDNISOLONE; MIFEPRISTONE; RATS; RATS, INBRED STRAINS; RECEPTORS, GLUCOCORTICOID;

EID: 73349095021     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-6-37     Document Type: Article

References (29)

1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747. 10.1146/annurev.immunol.23.021704.115707, 15771584.
2. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129:1953-1971. 10.1093/brain/awl075, 16632554.
3. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM. Differential regulation of central nervous system autoimmunity by T[H]1 and T[H]17 cells. Nat Med 2008, 14:337-342. 10.1038/nm1715, 18278054.
4. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 2008, 205:1535-1541. 10.1084/jem.20080159, 2442630, 18573909.
5. Brusaferri F, Candelise L. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol 2000, 247:435-442. 10.1007/s004150070172, 10929272.
6. Bolton C, Flower RJ. The effects of the anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat. Life Sci 1989, 45:97-104. 10.1016/0024-3205(89)90441-4, 2787464.
7. Lühder F, Reichardt HM. Traditional concepts and future avenues of glucocorticoid action in experimental autoimmune encephalomyelitis and multiple sclerosis therapy. Crit Rev Immunol 2009, 29:255-273.
8. Reichardt HM, Gold R, Lühder F. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Expert Rev Neurother 2006, 6:1657-1670. 10.1586/14737175.6.11.1657, 17144780.
9. Tischner D, Reichardt HM. Glucocorticoids in the control of neuroinflammation. Mol Cell Endocrinol 2007, 275:62-70. 10.1016/j.mce.2007.03.007, 17555867.
10. Chan J, Ban EJ, Chun KH, Wang S, McQualter J, Bernard C, Toh BH, Alderuccio F. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Autoimmunity 2008, 41:405-413. 10.1080/08916930802011258, 18568646.
11. Momcilovic M, Miljkovic Z, Popadic D, Markovic M, Savic E, Ramic Z, Miljkovic D, Mostarica-Stojkovic M. Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells. BMC Immunol 2008, 9:47. 10.1186/1471-2172-9-47, 2525626, 18700009.
12. Wüst S, Brandt J, Tischner D, Kleiman A, Tuckermann JP, Gold R, Lühder F, Reichardt HM. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol 2008, 180:8434-8443.
13. Sorrells SF, Sapolsky RM. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 2007, 21:259-272. 10.1016/j.bbi.2006.11.006, 1997278, 17194565.
14. Momcilovic M, Miljkovic Z, Popadic D, Miljkovic D, Mostarica-Stojkovic M. Kinetics of IFN-gamma and IL-17 expression and production in active experimental autoimmune encephalomyelitis in Dark Agouti rats. Neurosci Lett 2008, 447:148-152. 10.1016/j.neulet.2008.09.082, 18852028.
15. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810. 10.1084/jem.20071258, 2292220, 18391061.
16. Tuckermann JP, Kleiman A, McPherson KG, Reichardt HM. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci 2005, 42:71-104. 10.1080/10408360590888983, 15697171.
17. Beato M, Herrlich P, Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995, 83:851-857. 10.1016/0092-8674(95)90201-5, 8521509.
18. Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 2008, 4:525-533. 10.1038/ncprheum0898, 18762788.
19. Honer C, Nam K, Fink C, Marshall P, Ksander G, Chatelain RE, Cornell W, Steele R, Schweitzer R, Schumacher C. Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol Pharmacol 2003, 63:1012-1020. 10.1124/mol.63.5.1012, 12695529.
20. Linker RA, Weller C, Lühder F, Mohr A, Schmidt J, Knauth M, Metselaar JM, Gold R. Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long-term protective effects and enhanced efficacy of methylprednisolone formulations. Exp Neurol 2008, 211:397-406. 10.1016/j.expneurol.2008.02.005, 18394606.
21. Reder AT, Thapar M, Jensen MA. A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease. Neurology 1994, 44:2289-2294.
22. Engelhardt B. Role of glucocorticoids on T cell recruitment across the blood-brain barrier. Z Rheumatol 2000, 59((Suppl 2)II):18-21.
23. Dietrich JB. Endothelial cells of the blood-brain barrier: a target for glucocorticoids and estrogens?. Front Biosci 2004, 9:684-693. 10.2741/1272, 14766400.
24. Nguyen KB, McCombe PA, Pender MP. Increased apoptosis of T lymphocytes and macrophages in the central and peripheral nervous systems of Lewis rats with experimental autoimmune encephalomyelitis treated with dexamethasone. J Neuropathol Exp Neurol 1997, 56:58-69. 10.1097/00005072-199701000-00006, 8990129.
25. Yang Y, Merćep M, Ware CF, Ashwell JD. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 1995, 181:1673-1682. 10.1084/jem.181.5.1673, 2192012, 7536793.
26. Zipp F, Wendling U, Beyer M, Grieger U, Waiczies S, Wagenknecht B, Haas J, Weller M. Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells. J Neuroimmunol 2000, 110:214-222. 10.1016/S0165-5728(00)00337-4, 11024552.
27. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 2004, 1024:138-146. 10.1196/annals.1321.010, 15265778.
28. Miljkovic D, Momcilovic M, Stojanovic I, Stosic-Grujicic S, Ramic Z, Mostarica-Stojkovic M. Astrocytes stimulate interleukin-17 and interferon-gamma production in vitro. J Neurosci Res 2007, 85:3598-3606. 10.1002/jnr.21453, 17969033.
29. Momčilović M, Miljković D, Mostarica-Stojković M. Murine brain endothelial cells differently modulate interferon-γ and interleukin-17 production in vitro. Arch Biol Sci 2009, 61:29-36.